Nigella sativa L. and Its Active Compound Thymoquinone in the Clinical Management of Diabetes: A Systematic Review

Despite existing conventional hypoglycemic drugs to manage diabetes, their non-availability and cost in low-income countries coupled with the associated side effects remain a major concern. Consequently, exploring for alternative treatments to manage diabetes has been a continuous priority. Nigella...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahomoodally, Mohamad Fawzi, Aumeeruddy, Muhammad Zakariyyah, Legoabe, Lesetja J., Montesano, Domenico, Zengin, Gokhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602931/
https://www.ncbi.nlm.nih.gov/pubmed/36292966
http://dx.doi.org/10.3390/ijms232012111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602931/
https://www.ncbi.nlm.nih.gov/pubmed/36292966
http://dx.doi.org/10.3390/ijms232012111

Ejemplares similares